Login to Your Account

Study recommends plans for improving patient access in U.K.

By Nuala Moran
Staff Writer

Thursday, May 5, 2016

LONDON – A government-mandated study of how to accelerate access to new drugs will recommend that a select group of highly innovative products be singled out for special treatment, with plans agreed during development to take them all the way through regulatory approval, health technology assessment and commissioning at scale in the U.K.'s single payer NHS.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription